2022.Aug.11

Announcement of amendment of the Company's 2021 Annual Report

1.Date of receipt of letter from TPEx to request supplement or correction:2022/08/09 2.Deadline imposed for supplement or correction:2022/08/11 3.Content of supplement or correction:Pursuant to the instruction of Taipei Exchange, the Company amend p4~6 and p12~13 of its Chinese version of 2021 Annual Report; p6~p8 and p20~22 of its English version of 2021 Annual Report. 4.Countermeasures:Re-uploaded […]

HOMEWhat’s NewAnnouncementsAnnouncement of amendment of the Company’s 2021 Annual Report

Back to List

This article is password protected.

To view the content, please enter your password in the field below

2022.Aug.08

Announcement on behalf of AP Biosciences that preemptive rights forfeited by directors are over 50% and made available to specific persons

2022.Aug.12

Announcement on behalf of AP Biosciences to file application for Phase I human clinical trial of Bispecific Antibody, AP203, to US FDA